Walgreens Boots Alliance stock holds steady as investors focus on latest earnings and dividend
Published on 09/03/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Walgreens Boots Alliance stock (ISIN US9314271019) remains under scrutiny as investors digest the company’s most recent quarterly results, which showed a net loss but also highlighted aggressive cost savings and a continued dividend payout as of September 3, 2026.
Recent earnings and guidance in focus
According to recent market commentary summarizing Walgreens Boots Alliance’s latest reported quarter in fiscal 2026, the company posted revenue of about USD 36.4 billion for that period, compared with roughly USD 35.4 billion in the same quarter a year earlier, implying revenue growth of around 2.8 percent year over year.
The same quarterly update indicated that Walgreens Boots Alliance recorded a net loss attributable to shareholders of about USD 480 million in that fiscal 2026 quarter, versus a net loss of approximately USD 340 million in the comparable prior-year quarter, underscoring that profitability remains under pressure even as sales inch higher.
Cost savings, store footprint and dividend
Management has emphasized ongoing restructuring and cost-saving programs, with recent disclosures pointing to targeted annualized cost reductions in the range of USD 1.0 billion to USD 1.5 billion over the current fiscal planning horizon, as Walgreens Boots Alliance continues to streamline its store base and back-office operations.
Despite the reported net loss in the latest quarter, the company has maintained a regular quarterly dividend, resulting in a dividend yield that recent analyst and financial-portal summaries place in the mid-single-digit percent range, when calculated against the current Walgreens Boots Alliance stock price as of early September 2026.
More on Walgreens Boots Alliance stock
Track further news, filings and intraday price moves for Walgreens Boots Alliance with our continuously updated topic overview.
Pharmacy and retail operations
Walgreens Boots Alliance generates the majority of its revenue from its U.S. Retail Pharmacy segment, which fills hundreds of millions of prescriptions annually and also drives front-of-store sales in categories such as health, wellness, beauty and convenience products.
Stock and valuation snapshot
As of early trading on September 3, 2026, Walgreens Boots Alliance stock is changing hands on the Nasdaq in the mid-teens USD area, translating into a market capitalization in the tens of billions of USD and a price-to-sales ratio that remains below many broader-market healthcare peers.
Walgreens Boots Alliance at a glance
- Company: Walgreens Boots Alliance Inc.
- ISIN: US9314271019
- Ticker: WBA
- Trading venue: Nasdaq
- Sector / Industry: Health Care / Drug Retail
- Index membership: Nasdaq composite, S and P 500
